Literature DB >> 10878725

Primary and secondary pulmonary hypertension in systemic lupus erythematosus.

T L Pan1, J Thumboo, M L Boey.   

Abstract

OBJECTIVES: To describe the aetiology and clinical profile of primary and secondary pulmonary hypertension (PHT) in SLE patients.
METHODS: A retrospective study of SLE patients with PHT identified from a cohort of 786 SLE patients seen at Tan Tock Seng Hospital, Singapore.
RESULTS: 22 patients had primary and 24 patients had secondary PHT, with similar clinical features at presentation and a similar degree of pulmonary pressure elevation. Secondary PHT was due to valvular heart disease (50%), pulmonary embolism (13%), interstitial lung disease (8%) or a combination of these factors (29%). Primary PHT tended to present after a shorter duration of lupus than secondary PHT (8.8 vs 43.2 months, P=0.118). At presentation, Raynaud's phenomenon was present in 34.8% of subjects with primary or secondary PHT. Among those with secondary PHT, the presence of Raynaud's phenomenon was associated with a trend towards higher pulmonary artery systolic pressures (51.0 vs 40.5 mmHg, P=0. 101). 17% of patients with PHT died, but from causes unrelated to PHT.
CONCLUSION: Primary and secondary PHT are equally common in SLE patients. Secondary PHT is often multi-factorial, and Raynaud's phenomenon may be a marker for the severity of PHT in this group of patients.

Entities:  

Mesh:

Year:  2000        PMID: 10878725     DOI: 10.1191/096120300678828361

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  23 in total

1.  Is sildenafil effective in secondary pulmonary hypertension due to systemic lupus erythematosus? A case report.

Authors:  Ismail Hanta; Mesut Demir; Onur Akpinar; Ali Kocabas; Suleyman Ozbek
Journal:  Clin Rheumatol       Date:  2005-06-11       Impact factor: 2.980

2.  Pulmonary hypertension in a patient with adult-onset Stills disease.

Authors:  Eisha Mubashir; M Mubashir Ahmed; Samina Hayat; Maureen Heldmann; Seth Mark Berney
Journal:  Clin Rheumatol       Date:  2006-07-27       Impact factor: 2.980

3.  [Cardiovascular monitoring of patients with systemic lupus erythematosus].

Authors:  H Schotte; H Becker; W Domschke; M Gaubitz
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

4.  Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

Authors:  C P Denton; M Humbert; L Rubin; C M Black
Journal:  Ann Rheum Dis       Date:  2006-06-22       Impact factor: 19.103

Review 5.  Imaging of cardiovascular complications in patients with systemic lupus erythematosus.

Authors:  K Lin; D M Lloyd-Jones; D Li; Y Liu; J Yang; M Markl; J C Carr
Journal:  Lupus       Date:  2015-06-02       Impact factor: 2.911

Review 6.  Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis.

Authors:  Tian-Tian Lv; Peng Wang; Shi-Yang Guan; Hong-Miao Li; Xiao-Mei Li; Bin Wang; Hai-Feng Pan
Journal:  Ir J Med Sci       Date:  2017-12-18       Impact factor: 1.568

7.  The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.

Authors:  Zo Rakotoniaina; Pascal Guerard; Frederic Lirussi; Françoise Goirand; Luc Rochette; Monique Dumas; Marc Bardou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11-11       Impact factor: 3.000

8.  Adverse Events in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.

Authors:  Rennie L Rhee; Nicole B Gabler; Amy Praestgaard; Peter A Merkel; Steven M Kawut
Journal:  Arthritis Rheumatol       Date:  2015-09       Impact factor: 10.995

9.  Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension.

Authors:  Son-Mi Chung; Chang-Keun Lee; Eun Young Lee; Bin Yoo; Sang-Do Lee; Hee-Bom Moon
Journal:  Clin Rheumatol       Date:  2006-02-22       Impact factor: 2.980

10.  Volume manipulation by phlebotomy for cesarean section in a patient with pulmonary hypertension.

Authors:  Kazuhiro Watanabe; Takuo Hoshi; Masayuki Miyabe; Makoto Tanaka; Taro Mizutani
Journal:  J Anesth       Date:  2009-08-14       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.